Page 29 - Rna News Today

Researchers are finding clues to a potential remedy for consumption of the death cap species, a potentially lethal mushroom.

Avidity Biosciences (NASDAQ:RNA – Get Rating) had its price target reduced by Wells Fargo & Company from $55.00 to $50.00 in a research note released on Thursday, The Fly reports. Several other analysts also recently commented on the stock. Needham & Company LLC reaffirmed a buy rating and set a $35.00 price objective on shares […]

MyJournals.org - Science - IJMS, Vol. 24, Pages 8716: SERPINE1 mRNA Binding Protein 1 Is Associated with Ischemic Stroke Risk: A Comprehensive Molecular–Genetic and Bioinformatics Analysis of SERBP1 SNPs (International Journal of Molecular Sciences)

Avidity Biosciences (NASDAQ:RNA – Get Rating) and Eliem Therapeutics (NASDAQ:ELYM – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, institutional ownership and valuation. Analyst Recommendations This is a breakdown of recent recommendations […]

Chinas first domestically developed mRNA vaccine for COVID-19 was initially put into use in Shijiazhuang, North Chinas Hebei Province on Sunday.

PARIS (AP) — A French citizen and another holding dual French-Irish nationality have...

In this application note, Agilent Technologies emphasizes the importance of good-quality RNA for successful downstream applications and highlights the use of their automated electrophoresis instruments in determining RNA integrity. Each instrument provides an objective quality metric that assesses RNA integrity, quantity, and size, allowing researchers to evaluate RNA from different extraction methods or tissues and in vitro transcription. The note also highlights peer-reviewed publicat

- linearDNA™ Gaining Momentum as a Differentiated DNA Template for mRNA Production, Company Identifies Early Development-Stage Acquisition Target to Potentially Expand... | May 11, 2023

Aldevron is expanding its mRNA production capabilities to include lipid nanoparticle (LNP) encapsulation and aseptic fill-finish capabilities.

At the NYSANA rally on May 9, CRNAs pushed for legislation that would recognize their profession. Despite advanced training, CRNAs are not recognized in New Yor